ARIXTRA (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the ARIXTRA drug offered from Physicians Total Care, Inc.. This Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: fondaparinux sodium
SUBSTANCE NAME: FONDAPARINUX SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-11-17
END MARKETING DATE: 0000-00-00


ARIXTRA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionARIXTRA from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/.6mL)
START MARKETING DATE: 2004-11-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-5501_b9d65d39-a065-4ce1-8c67-df4139d291bf
PRODUCT NDC: 54868-5501
APPLICATION NUMBER: NDA021345

Other FONDAPARINUX SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dr. Reddy’s Laboratories Inc.Fondaparinux Sodium
Dr. Reddy’s Laboratories LimitedFondaparinux Sodium
Mylan Institutional LLCFondaparinux Sodium
Physicians Total Care, Inc.ARIXTRA